Experimental Ebola vaccine to be tested in humans in September

417137

The first clinical trials of an Ebola vaccine are scheduled for September.

The drug, now being developed by American experts, has already shown positive results in primates. Scientists at the National Institute of Health’s infectious will try to develop a vaccine as quickly as possible.

Experts say that despite the imminent start of human trials of the Ebola vaccine, the first available preventive vaccinations will be available in a few years. One of the main reasons is the lack of funding for important clinical trials. Four new drugs are currently in development. Dr. Thomas Geisbert of the University of Texas said the vaccine will be released in the next 2-6 years. Geisbert says: There are at least four vaccines that could protect monkeys from Ebola. But the next level depends on financial support from the small companies that develop these vaccines.”

Geisbert, who has been studying the Ebola virus since 1988, said there are 4 preventative vaccines that look promising, yielded positive results when tested on primates. And now research groups are trying to raise funds to conduct research on humans.

Source: nauka24news.ru/